SCAPE-HIV

  • Research type

    Research Study

  • Full title

    SARS CoV2 Antibody Prevalence in an Adult HIV Cohort (SCAPE-HIV study)

  • IRAS ID

    290112

  • Contact name

    Tristan Barber

  • Contact email

    t.barber@nhs.net

  • Sponsor organisation

    Royal Free London NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 6 months, 0 days

  • Research summary

    The study is looking to find out how many people living with HIV (PLWH) have been infected with SARS-CoV2 through the detection of specific antibodies (via a blood test).

    The presence of these antibodies is a marker of whether PLWH have been infected before and will help us better understand whether living with HIV puts people at a high risk of becoming infected with SARS-CoV2 compared to the general population, and which other factors of characteristics may affect this risk. This will help us identify who may be more at risk of getting COVID-19 in the future and will help us plan for when a COVID-19 vaccine eventually becomes available.

  • REC name

    Yorkshire & The Humber - Leeds West Research Ethics Committee

  • REC reference

    21/YH/0035

  • Date of REC Opinion

    1 Feb 2021

  • REC opinion

    Favourable Opinion